Ahmadipour Yahya, Kaur Monika, Pierscianek Daniela, Gembruch Oliver, Oppong Marvin Darkwah, Mueller Oliver, Jabbarli Ramazan, Glas Martin, Sure Ulrich, El Hindy Nicolai
Department of Neurosurgery, University Hospital Essen, Essen, Germany.
Division of Clinical Neurooncology, Department of Neurology, University Hospital Essen, Essen, Germany.
J Neurol Surg A Cent Eur Neurosurg. 2019 Jul;80(4):262-268. doi: 10.1055/s-0039-1685170. Epub 2019 Apr 9.
Extent of resection (EOR) and Karnofsky Performance Status (KPS) are at odds in glioblastoma (GBM) surgery, that is, the anticipated postoperative disability limits the EOR. This study analyzes the correlation of different surgical modalities with the resulting physical status and survival of patients with GBM.
A total of 565 patients with primary GBM were operated on in a single institution between 2006 and 2014. Possible surgical modalities comprised supratotal resection (SLR), gross total resection (GTR; ≥ 95% by volume), tumor debulking (TDB; ≤ 95% by volume), and stereotactic biopsy (SB). Pre- and postoperative KPS before and up to 4 weeks after surgery as well as overall survival (OS) rate were determined retrospectively. Hazard ratio (HR) and 95% confidence intervals were calculated using a Cox proportional hazards model.
Median postoperative KPS was ≥ 70, irrespective of surgical modality. Mean OS was 12.5 months. Multivariate analysis revealed age ≥ 70 years (HR: 1.93), preoperative KPS < 70 (HR: 2.15), and unmethylation in promoter (HR: 1.27) as independent factors for worse OS. Regarding surgical modality, SB was associated with the worst survival (HR: 2.3) followed by TDB (HR: 1.36). SLR was inferior to GTR (HR: 1.27).
Higher EOR in patients with GBM does not seem inevitably correlated with increasing functional impairment, but better survival, provided there is a balanced preoperative indication. Nevertheless, SLR does not seem to be superior to GTR. Whenever possible, maximal safe resection should be considered in patients with GBM, even if an EOR ≥ 95% is not possible.
在胶质母细胞瘤(GBM)手术中,切除范围(EOR)和卡氏功能状态评分(KPS)存在矛盾,即预期的术后残疾限制了切除范围。本研究分析了不同手术方式与GBM患者术后身体状况及生存情况的相关性。
2006年至2014年期间,在单一机构对565例原发性GBM患者进行了手术。可能的手术方式包括次全切除(SLR)、全切除(GTR;体积≥95%)、肿瘤减瘤(TDB;体积≤95%)和立体定向活检(SB)。回顾性确定术前及术后直至术后4周的KPS以及总生存率(OS)。使用Cox比例风险模型计算风险比(HR)和95%置信区间。
无论手术方式如何,术后KPS中位数≥70。平均OS为12.5个月。多因素分析显示年龄≥70岁(HR:1.93)、术前KPS<70(HR:2.15)和启动子未甲基化(HR:1.27)是OS较差的独立因素。关于手术方式,SB与最差的生存率相关(HR:2.3),其次是TDB(HR:1.36)。SLR不如GTR(HR:1.27)。
GBM患者中更高的切除范围似乎并不必然与功能损害增加相关,而是与更好的生存率相关,前提是有平衡的术前指征。然而,SLR似乎并不优于GTR。对于GBM患者,只要有可能,应考虑进行最大安全切除,即使无法实现切除范围≥95%。